BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging & Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging & Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260206T133000
DTEND;TZID=Europe/Vienna:20260206T143000
DTSTAMP:20260509T223439
CREATED:20251004T070000Z
LAST-MODIFIED:20260126T130413Z
UID:2840-1770384600-1770388200@esmit.eanm.org
SUMMARY:Innovations in Theranostics for Neuroblastoma
DESCRIPTION:This course provides a comprehensive update on instrumental and radiopharmaceutical innovations in the diagnosis and treatment of neuroblastoma. Participants will explore current and emerging imaging modalities\, with a comparative analysis of MIBG\, MFBF\, FDOPA\, and Gallium-based tracers\, highlighting their evolving roles in staging\, risk stratification\, and response assessment. \n\n\n\nThe course will address recent changes in clinical practice and the challenges these advancements pose for pediatric oncologists and nuclear medicine physicians\, emphasizing multidisciplinary decision-making. \n\n\n\nIn addition\, the program will review novel therapeutic strategies for refractory and relapsed neuroblastoma\, with a focus on radioligand therapy and its integration with immunotherapy approaches\, including CAR-T cell therapy. Through state-of-the-art updates and clinical perspectives\, the course aims to equip clinicians with practical insights for optimizing diagnostic accuracy and therapeutic outcomes in this complex pediatric malignancy. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\nDescribe recent instrumental and radiopharmaceutical innovations in the diagnosis and management of neuroblastoma.\n\n\n\nCompare the clinical indications\, advantages\, and limitations of MIBG\, MFBF\, FDOPA\, and Gallium-based imaging tracers in neuroblastoma.\n\n\n\nEvaluate how emerging imaging techniques are changing staging\, risk stratification\, and treatment response assessment in pediatric patients.\n\n\n\nIdentify current challenges and unmet needs faced by pediatric oncologists and nuclear medicine physicians in integrating new diagnostic tools into clinical practice.\n\n\n\nDiscuss the principles and clinical applications of radioligand therapy in refractory and relapsed neuroblastoma.\n\n\n\nAssess the potential role of combined treatment strategies\, including radioligand therapy with immunotherapy and CAR-T cell therapy\, in improving patient outcomes.\n\n\n\nApply multidisciplinary decision-making approaches to optimize personalized diagnostic and therapeutic strategies for children with neuroblastoma.\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\nNuclear Medicine Physicians\n\n\n\n\n \n\n\n\n \n\n\n\nSuggested Reading\n\n\n\n \n\n\n\nSe Whee Sammy Park et al. Front Oncol 14:1408729. doi: 10.3389/fonc.2024.1408729 \, Lise Borgwardt et al\, The Journal of Nuclear Medicine (2024). DOI: 10.2967/jnumed.123.267256   \n\n\n\n \n\n\n\n\n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n \n\n\n\n\n\nJulian RogaschSpeaker \n\n\n\n\n\nBart de KeizerSpeaker \n\n\n\n\n\nMarie LuporsiModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/innovations-in-theranostics-for-neuroblastoma/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260220T133000
DTEND;TZID=Europe/Vienna:20260220T143000
DTSTAMP:20260509T223439
CREATED:20251004T070000Z
LAST-MODIFIED:20260217T091153Z
UID:2843-1771594200-1771597800@esmit.eanm.org
SUMMARY:Beyond Single Modality: The Future of Cancer Staging with Hybrid Scanners
DESCRIPTION:This webinar will be on the future of cancer staging with hybrid imaging technologies. Participants will gain an overview of advanced PET/CT\, SPECT/CT\, and PET/MRI systems\, learning how hybrid imaging enhances diagnostic accuracy and supports more precise clinical decisions.The session will explore the practical challenges technologists face when working with these cutting-edge systems\, including image acquisition\, processing\, and interpretation\, while highlighting the technical skills needed for effective operation.We’ll also discuss educational gaps and training opportunities for radiographers and technologists\, presenting strategies such as hands-on workshops\, e-learning\, and mentorship to support professional development.By the end of this webinar\, attendees will have a clear understanding of the evolving role of technologists in hybrid oncological imaging and be inspired to embrace innovation\, lifelong learning\, and interdisciplinary collaboration. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nDescribe the most advanced hybrid imaging technologies used for oncological staging in nuclear medicine Understand the key features of PET/CT\, SPECT/CT\, and PET/MRI systems\n\n\n\nDistinguish the main advantages and limitations of hybrid modalities in clinical oncology\n\n\n\nUnderstand the added value of multimodality imaging compared with single-modality approaches Identify cases where hybrid imaging improves sensitivity\, specificity\, or diagnostic accuracy Recognize how functional-anatomical integration supports more precise clinical decisions\n\n\n\nAnalyze the main challenges faced by technologists in the acquisition\, processing\, and interpretation of hybrid imaging data Highlight practical issues (e.g.\, image registration\, calibration\, artifacts\, acquisition timing)Reflect on the technical skills required to operate hybrid systems effectively\n\n\n\nIdentify educational gaps and learning challenges encountered by radiographers/technologists when adopting new hybrid technologies Recognize organizational\, infrastructural\, and educational barriers (e.g.\, equipment availability\, supervision\, time constraints) Assess variations in training opportunities across European contexts\n\n\n\nPropose strategies and training programs for integrating hybrid skills into radiotherapy technician (RTM) programs\, fostering critical awareness of the evolving role of the technician in the context of hybrid oncology imaging.Suggest training models (advanced courses\, internships at centers of excellence\, e-learning\, hands-on workshops)Outline a roadmap for continuous development (on-the-job training\, certifications\, mentorships)\n\n\n\nPromote a proactive mindset toward technological innovation and self-development\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nNuclear medicine Technologists\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nOliver RamsaySpeaker \n\n\n\n\n\nNia HopsonSpeaker \n\n\n\n\n\nPaolo TurcoModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/beyond-single-modality-the-future-of-cancer-staging-with-hybrid-scanners/
CATEGORIES:Live Webinars
END:VEVENT
END:VCALENDAR